Simulation as a tool for managing Ebola infection

Seroprevalence of brucellosis and associated factors among livestock slaughtered in Oko-Oba abattoir, Lagos State, southwestern Nigeria

Introduction

Brucella infection, a neglected tropical zoonosis, poses public health threat to abattoir workers in developing countries including Nigeria. Oko-Oba abattoir is one of the largest abattoirs in the country that collects livestock from different parts of the country. This study determined the prevalence and factors associated with seropositivity of brucellosis among livestock slaughtered at Oko-Oba abattoir.

Methods

A cross-sectional study was conducted from January to May 2018. A total of 473 serum samples were collected from livestock at the abattoir and tested for antibodies to Brucella species using the Rose Bengal Plate Test (RBPT) and indirect Enzyme Linked Immunosorbent Assay (iELISA). Data were analyzed using descriptive statistics and chi square test (p < 0.05).

Results

Overall seroprevalence values were 15.3% (RBPT) and 16.3% (iELISA) among the livestock slaughtered at the Oko-Oba abattoir. Seroprevalence of 17.2% (RBPT) and 15.8% (iELISA) in cattle; 15.1% (RBPT) and 14.5% (iELISA) in goat; and 8.3% (RBPT) and 23.3% (iELISA) in sheep were obtained. Higher seroprevalence were recorded among females in cattle (18.8% iELISA) and sheep (23.1% iELISA) while male goats had average value higher (14.7% iELISA) than the female (p > 0.05).

Conclusion

Presence of Brucella infection among slaughtered livestock was confirmed at Oko-Oba abattoir, Lagos State, Nigeria and poses a threat to abattoir workers and public health. Control of the disease in livestock and use of personal protective gear is recommended.

Secondary metabolites extracted from marine sponge associated Comamonas testosteroni and Citrobacter freundii as potential antimicrobials against MDR pathogens and hypothetical leads for VP40 matrix protein of Ebola virus: an in vitro and in silico investigation

The current study explores therapeutic potential of metabolites extracted from marine sponge (Cliona sp.)-associated bacteria against MDR pathogens and predicts the binding prospective of probable lead molecules against VP40 target of Ebola virus. The metabolite-producing bacteria were characterized by agar overlay assay and as per the protocols in Bergey's manual of determinative bacteriology. The antibacterial activities of extracted metabolites were tested against clinical pathogens by well-diffusion assay. The selected metabolite producers were characterized by 16S rDNA sequencing. Chemical screening and Fourier Transform Infrared (FTIR) analysis for selected compounds were performed. The probable lead molecules present in the metabolites were hypothesized based on proximate analysis, FTIR data, and literature survey. The drug-like properties and binding potential of lead molecules against VP40 target of Ebola virus were hypothesized by computational virtual screening and molecular docking. The current study demonstrated that clear zones around bacterial colonies in agar overlay assay. Antibiotic sensitivity profiling demonstrated that the clinical isolates were multi-drug resistant, however; most of them showed sensitivity to secondary metabolites (MIC-15 μl/well). The proximate and FTIR analysis suggested that probable metabolites belonged to alkaloids with O-H, C-H, C=O, and N-H groups. 16S rDNA characterization of selected metabolite producers demonstrated that 96% and 99% sequence identity to Comamonas testosteroni and Citrobacter freundii, respectively. The docking studies suggested that molecules such as Gymnastatin, Sorbicillactone, Marizomib, and Daryamide can designed as probable lead candidates against VP40 target of Ebola virus.